Related Experiment Video

Updated: Jul 18, 2026

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
06:04

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

[Vanilloid receptors: structure, regulatory functions, pharmacology, therapeutic potential]

N Iu Mironov, V V Churiukanov

    Eksperimental'Naia I Klinicheskaia Farmakologiia
    |December 13, 2006
    PubMed

    Insights

    Transient receptor potential vanilloid (TRPV1) channels, activated by heat and capsaicin, play roles in bodily functions and disease. This review covers TRPV1 structure, regulation, and therapeutic potential.

    Area of Science:

    • Molecular Biology
    • Neuroscience
    • Physiology

    Context:

    • Transient receptor potential vanilloid (TRPV1) channels are key ion channels involved in sensory perception and physiological regulation.
    • TRPV1 activation by stimuli like heat, acidosis, and capsaicin influences various biological processes.
    • Dysregulation of TRPV1 is implicated in several pathological conditions.

    Purpose:

    • To provide a comprehensive review of the structure, function, and activation mechanisms of TRPV1.
    • To explore the chemistry of vanilloid receptors and their endogenous ligands.
    • To discuss the therapeutic potential of TRPV1 agonists and antagonists based on experimental and clinical data.

    Summary:

    • This review details the structure, regulatory functions, and activation mechanisms of Transient Receptor Potential Vanilloid (TRPV1) channels.
    • It examines the roles of vanilloid receptor agonists and antagonists, including endogenous ligands.
    • The therapeutic implications of targeting TRPV1 in various conditions are considered, supported by experimental and clinical findings.

    Impact:

    • Understanding TRPV1 mechanisms offers insights into pain, inflammation, and other physiological processes.
    • This knowledge can guide the development of novel therapeutic strategies targeting TRPV1.
    • The review highlights the translational potential of vanilloid receptor research in clinical applications.

    More Related Videos

    Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 109:39

    Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

    Published on: February 13, 2018

    Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV412:09

    Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

    Published on: December 31, 2013

    Related Concept Videos

    Opioid Receptors: Overview01:22

    Opioid Receptors: Overview

    Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
    Drug-Receptor Interaction: Agonist01:25

    Drug-Receptor Interaction: Agonist

    Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
    Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
    G Protein-coupled Receptors01:15

    G Protein-coupled Receptors

    G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
    GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
    G-protein Coupled Receptors01:21

    G-protein Coupled Receptors

    G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
    G Protein-coupled Receptors01:15

    G Protein-coupled Receptors

    G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
    GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
    Analgesia and Pain Management01:25

    Analgesia and Pain Management

    Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...